Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis

Scandinavian Journal of Rheumatology

Volumn 35, Issue 2, 2006, Pages 133-137

  Peterlana, D ^a   Puccetti, A ^b,c   Caramaschi, P ^a   Biasi, D ^a   Beri, R ^a   Simeoni, S ^a   Corrocher, R ^a   Lunardi, C ^a,d  

^a UNIVERSITY OF VERONA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Section of Internal Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; ENDOTHELIN 1; FOLIC ACID; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN HINFI; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FIBROSIS; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 33646466924     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740500385584     Document Type: Article

References (15)

1. Seilbold JR. Scleroderma. In Ruddy S, Harris ED, Sledge CB, editors. Kelley's textbook of rheumatology, 6th ed. Philadelphia: Saunders, 2001:1211-39.
2. Kahaleh MB. Endothelin, an endothelial dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. Arthritis Rheum 1991;34:978-83.
3. Shi-Wen X, Denton CP, Dashwood MR, Holmes AM, Bou-Gharios G, Pearson JD, et al. Fibroblast matrix gene expression and connective tissue remodelling: role of endothelin-1. J Invest Dermatol 2001;116:417-25.
4. Hasegava M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 1999;117:159-65.
5. Ong VH, Evans LA, Shiwen X, Fisher IB, Rajkumar V, Abraham DJ, et al. Monocyte chemoattractant protein 3 as a mediator of fibrosis: overexpression in systemic sclerosis and the type 1 tight-skin mouse. Arthritis Rheum 2003;48:1979-91.
6. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocystinemia: an independent risk factor for vascular disease. New Engl J Med 1991;324:1149-55.
7. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomosyst(e)inemia is associated with impaired endothelium-dependent vasodilatation in humans. Circulation 1997;95:1119-21.
8. Sung FL, Siow YL, Wang G, Lyn EG, K. O. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol Cell Biochem 2001;216:121-8.
9. Marasini B, Casari S, Bestetti A, Maioli C, Cugno M, Zeni S, et al. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon. J Rheumatol 2000;27:2621-3.
10. Caramaschi P, Martinelli N, Biasi D, Carletto A, Faccini G, Volpe A, et al. Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. J Rheumatol 2003;30:298-304.
11. Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, et al. In atherosclerosis antibodies against HSP60 bind human cytomegalovirus- derived proteins and induce apoptosis of non-stressed endothelial cells. Lancet 2003;362:1971-7.
12. Drunat S, Moatti N, Paul JL, Cogny A, Benoit MO, Demuth K. Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 2001;268:5287-94.
13. Distler O, Pap T, Kowal-Bielecka O, Meyringer R, Guiducci S, Landthaler M, et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis. Arthritis Rheum 2001;11:2665-78.
14. Chen P, Shibata M, Zidovetzki R, Fisher M, Zlokovic BV, Hofman FM. Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol 2001;116:62-73.
15. Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, Pessotto U, et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from Northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 1998;91:4158-63.